Meng (marie) Zhang
Vice President
Pharmaceuticals
VcanBio Center for Translational Biotechnology
China
Biography
Dr. Meng (Marie) Zhang joined VcanBio CTB in April of 2016 as Vice President of Preclinical Development. Prior to joining VcanBio CTB, she served as a leading scientist and team manager on the research and development of the advanced platform for biomolecule detection and clinical diagnostics in US Genomics, a developer of single-molecule technologies for biodefense and clinical diagnostics, and later in NABsys to develop solid-state nanodetectors for high definition whole genome mapping. With more than 15 years’ experience in the biotech industry, Dr. Zhang is an expert on process development and product quality control, specializing in single biomolecule and biomarker analysis, protein chemistry and cell biology. Dr. Zhang also has experience in iPSC differentiation toward endothelial and hematopoietic cells, epigenetic modification, and gene functionality regulation. Dr. Zhang received her Ph. D degree in biochemistry & molecular medicine from University of Massachusetts Medical School and a B. S degree in pharmaceuticals from Shanghai Medical College at Fudan University.
Research Interest
Biochemistry & molecular medicine, Genomics
